Lista de obras - G Petrova - Dominio Público Uruguay

Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation

artículo científico publicado en 2017

Analysis of patients’ access to reimbursed biotechnological medicines for multiple sclerosis in Bulgaria and Greece

artículo científico publicado en 2021

Availability and reimbursement of biological products for severe asthma in Bulgaria

scientific article published on 18 August 2020

Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets

artículo científico publicado en 2018

Benefits of investment into modern medicines in Central-Eastern European countries.

artículo científico

Chronic Hepatitis C-Related Cirrhosis Hospitalization Cost Analysis in Bulgaria

artículo científico publicado en 2017

Clinical characteristics, treatment patterns, and socio-economic burden of COPD in Bulgaria

artículo científico publicado en 2017

Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries

article

Comparative Price Analysis of Biological Products for Treatment of Rheumatoid Arthritis

artículo científico publicado en 2018

Comparative analysis of the access to health-care services and breast cancer therapy in 10 Eastern European countries

artículo científico publicado en 2020

Comparison of health-related quality-of-life measurement instruments in diabetic patients

artículo científico publicado en 2014

Complex regional pain syndrome acceptance and the alternative denominations in the medical literature

artículo científico publicado en 2012

Cost of outpatient hypertension pharmacotherapy: comparative study between Bulgaria and Serbia.

artículo científico publicado en 2009

Cost of severe hypoglycaemia in nine European countries

artículo científico publicado en 2016

Cost-Minimization Analysis of Direct Cost of Sevelamer Carbonate and Lanthanum Carbonate in the Treatment of Patients with Chronic Kidney Disease Not on Dialysis in Bulgaria

scientific article published on 01 September 2015

Cost-effectiveness analysis of different types of labor for singleton pregnancy: real life data

artículo científico publicado en 2014

Cost-effectiveness of cardiomyopathy ambulatory care with sacubitril/valsartan vs standard therapy after COVID-19 in Kazakhstan

artículo científico publicado en 2024

EQ-5D studies in cardiovascular diseases in eight Central and Eastern European countries: a systematic review of the literature.

artículo científico publicado en 2018

EQ-5D studies in musculoskeletal and connective tissue diseases in eight Central and Eastern European countries: a systematic literature review and meta-analysis.

artículo científico

EQ-5D studies in nervous system diseases in eight Central and East European countries: a systematic literature review

artículo científico publicado en 2019

Economic consequences of the vaccination against hepatitis A in the Bulgarian healthcare setting

artículo científico publicado en 2014

Economic evaluation of continuous subcutaneous insulin infusion for children with diabetes - a pilot study: CSII application for children - economic evaluation

artículo científico publicado en 2013

Economic evaluation of different screening alternatives for patients with clinically suspected acute deep vein thrombosis

artículo científico publicado en 2013

Evaluating potentially inappropriate medications in elderly patients in a pharmacy setting in Bulgaria: A pilot study utilizing the EU (7)-PIM List

artículo científico publicado en 2023

Health technology assessment in the Balkans: opportunities for a balanced drug assessment system

artículo científico publicado en 2014

Humanistic and economic aspects of haemophilia treatment in Bulgaria. Comparison between two therapeutic approaches: prophylactic vs. on-demand treatment

artículo científico publicado en 2014

ISO 9001 certification for hospitals in Bulgaria: does it help service?

artículo científico publicado en 2014

Life expectancy and survival analysis of patients with diabetes compared to the non diabetic population in Bulgaria

artículo científico publicado en 2020

Patient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of Experts.

artículo científico publicado en 2018

Pharmaceutical Regulation in Central and Eastern European Countries: A Current Review.

artículo científico publicado en 2017

Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries

scientific article published on 01 December 2019

Policies for biosimilar uptake in Europe: An overview.

artículo científico publicado en 2017

Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries

artículo científico publicado en 2017

Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA

artículo científico publicado en 2019

Quality of Life and Cost Study of Rheumatoid Arthritis Therapy With Biological Medicines

scientific article published on 18 July 2018

Quality of life of patients with cardiomyopathy treated with sacubitril/valsartan vs. standard therapy during or after COVID-19 in Kazakhstan

artículo científico publicado en 2024

Rationalizing the introduction and use of pharmaceutical products: The role of managed entry agreements in Central and Eastern European countries

artículo científico publicado en 2018

Real World Experience of Disease Activity in Patients With Rheumatoid Arthritis and Response to Treatment With Varios Biologic DMARDs

artículo científico publicado en 2018

Safety assessment of newly marketed herbal medicines--methodological approach (Ginkgo biloba example in Bulgaria).

artículo científico publicado en 2007

The European challenges of funding orphan medicinal products

artículo científico publicado en 2018

The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications.

artículo científico publicado en 2017

The applicability of the tetraclass model to the management of the patient satisfaction in the pharmacies

artículo científico publicado en 2009

Use of biologics for psoriasis in Central and Eastern European countries

artículo científico

Use of complementary and alternative medicine by children in Europe: published data and expert perspectives

artículo científico publicado en 2012

Lista de obras de G Petrova

Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation

Analysis of patients’ access to reimbursed biotechnological medicines for multiple sclerosis in Bulgaria and Greece

Availability and reimbursement of biological products for severe asthma in Bulgaria

Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets

Benefits of investment into modern medicines in Central-Eastern European countries.

Chronic Hepatitis C-Related Cirrhosis Hospitalization Cost Analysis in Bulgaria

Clinical characteristics, treatment patterns, and socio-economic burden of COPD in Bulgaria

Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries

Comparative Price Analysis of Biological Products for Treatment of Rheumatoid Arthritis

Comparative analysis of the access to health-care services and breast cancer therapy in 10 Eastern European countries

Comparison of health-related quality-of-life measurement instruments in diabetic patients

Complex regional pain syndrome acceptance and the alternative denominations in the medical literature

Cost of outpatient hypertension pharmacotherapy: comparative study between Bulgaria and Serbia.

Cost of severe hypoglycaemia in nine European countries

Cost-Minimization Analysis of Direct Cost of Sevelamer Carbonate and Lanthanum Carbonate in the Treatment of Patients with Chronic Kidney Disease Not on Dialysis in Bulgaria

Cost-effectiveness analysis of different types of labor for singleton pregnancy: real life data

Cost-effectiveness of cardiomyopathy ambulatory care with sacubitril/valsartan vs standard therapy after COVID-19 in Kazakhstan

EQ-5D studies in cardiovascular diseases in eight Central and Eastern European countries: a systematic review of the literature.

EQ-5D studies in musculoskeletal and connective tissue diseases in eight Central and Eastern European countries: a systematic literature review and meta-analysis.

EQ-5D studies in nervous system diseases in eight Central and East European countries: a systematic literature review

Economic consequences of the vaccination against hepatitis A in the Bulgarian healthcare setting

Economic evaluation of continuous subcutaneous insulin infusion for children with diabetes - a pilot study: CSII application for children - economic evaluation

Economic evaluation of different screening alternatives for patients with clinically suspected acute deep vein thrombosis

Evaluating potentially inappropriate medications in elderly patients in a pharmacy setting in Bulgaria: A pilot study utilizing the EU (7)-PIM List

Health technology assessment in the Balkans: opportunities for a balanced drug assessment system

Humanistic and economic aspects of haemophilia treatment in Bulgaria. Comparison between two therapeutic approaches: prophylactic vs. on-demand treatment

ISO 9001 certification for hospitals in Bulgaria: does it help service?

Life expectancy and survival analysis of patients with diabetes compared to the non diabetic population in Bulgaria

Patient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of Experts.

Pharmaceutical Regulation in Central and Eastern European Countries: A Current Review.

Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries

Policies for biosimilar uptake in Europe: An overview.

Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries

Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA

Quality of Life and Cost Study of Rheumatoid Arthritis Therapy With Biological Medicines

Quality of life of patients with cardiomyopathy treated with sacubitril/valsartan vs. standard therapy during or after COVID-19 in Kazakhstan

Rationalizing the introduction and use of pharmaceutical products: The role of managed entry agreements in Central and Eastern European countries

Real World Experience of Disease Activity in Patients With Rheumatoid Arthritis and Response to Treatment With Varios Biologic DMARDs

Safety assessment of newly marketed herbal medicines--methodological approach (Ginkgo biloba example in Bulgaria).

The European challenges of funding orphan medicinal products

The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications.

The applicability of the tetraclass model to the management of the patient satisfaction in the pharmacies

Use of biologics for psoriasis in Central and Eastern European countries

Use of complementary and alternative medicine by children in Europe: published data and expert perspectives